The Therapeutic Effect of Dabuyin Wan on Male Breast Development and Its Impact on Sex Hormone Levels
Abstract
Objective: To investigate the efficacy of Dabuyin Wan (Concentrated Pills) in the treatment of prepubertal gynecomastia in boys and to analyze its impact on sex hormone levels. Methods: A total of 100 boys with gynecomastia diagnosed and treated in our hospital from July 2022 to February 2025 were selected and randomly divided into two groups using a random number table, with 50 cases in each group. The control group received non-pharmacological treatment, while the observation group was treated with Dabuyin Wan (Concentrated Pills). Both groups continued treatment for 6 months. Clinical efficacy, TCM syndrome scores, sex hormone levels [estradiol (E2), luteinizing hormone (LH), testosterone (T), prolactin (PRL)], and adverse reactions were compared between the two groups. Results: The total clinical effective rate in the observation group was higher than that in the control group (χ² = 5.316, P < 0.05). After treatment, the TCM syndrome score in the observation group was lower than that in the control group (t = 15.513, P < 0.05). After treatment, E2, LH, and PRL levels in the observation group were lower than those in the control group, while the T level in the observation group was higher than that in the control group (t = 5.819, 11.000, 7.275, 9.524, respectively; P < 0.05 for all). There was no significant difference in the incidence of adverse reactions between the two groups. Conclusion: The use of Dabuyin Wan (Concentrated Pills) for prepubertal gynecomastia in boys can improve clinical outcomes, alleviate clinical symptoms, modulate sex hormone levels, and demonstrate a favorable safety profile.
References
Shen B, Yang Y, Yao H, et al., 2022, Analysis of Clinical Characteristics and Influencing Factors of Adolescent Male Gynecomastia. Zhejiang Medical Journal, 44(8): 837–840 + 845.
Mannu G, Sudul M, Bettencourt-Silva J, et al., 2018, Role of Tamoxifen in Idiopathic Gynecomastia: A 10-Year Prospective Cohort Study. Breast J, 24(6): 1043–1045.
Wang X, Zhao X, Zhang W, et al., 2022, Verified Cases of Guo Chengjie, a Master of Traditional Chinese Medicine, in Treating Male Gynecomastia. Shandong Journal of Traditional Chinese Medicine, 41(1): 98–100.
Li D, Shi H, Zhang Y, et al., 2012, Applicability of the Tanner Staging Visual Self-Assessment Method Among Urban Adolescents. Chinese Journal of School Health, 33(9): 1029–1032.
Lin Y, Tang H, 2003, Modern Traditional Chinese Medicine Mammary Gland Pathology. People’s Medical Publishing House, Beijing: 163–169.
Laimon W, El-Hawary A, Aboelenin H, et al., 2021, Prepubertal Gynecomastia Is Not Always Idiopathic: Case Series and Review of the Literature. Eur J Pediatr, 180(3): 977–982.
Vojvodic M, Xu F, Cai R, et al., 2019, Anabolic-Androgenic Steroid Use Among Gynecomastia Patients: Prevalence and Relevance to Surgical Management. Ann Plast Surg, 83(3): 258–263.
Zhu Y, Shen Z, Tang Z, et al., 2018, Efficacy Evaluation of Xiaojin Capsules in the Treatment of Elderly Male Gynecomastia. Geriatrics & Health Care, 24(4): 427–430.
Wang D, Zhang M, Xing Y, et al., 2019, Qin Guozheng’s Treatment of Adolescent Male Gynecomastia by Nourishing the Liver and Kidney, Strengthening the Spleen and Stomach, and Dispersing Blood Stasis. Shandong Journal of Traditional Chinese Medicine, 38(11): 1055–1057 + 1061.
Zhang C, Yu M, Lai Y, et al., 2022, Clinical Observation on the Treatment of Children With Simple Premature Breast Development by Nourishing Yin and Purging Fire Formula. Journal of Guangzhou University of Traditional Chinese Medicine, 39(9): 2028–2033.
Miyamoto Y, Kawaguchi H, Tanimoto A, 2018, Relationship Between Morphological Development and Sex Hormone Receptor Expression of Mammary Glands With Age in Male Rats. Exp Anim, 67(3): 361–371.
Ciccone M, Trousdell M, Santos C, 2020, Characterization of Organoid Cultures to Study the Effects of Pregnancy Hormones on the Epigenome and Transcriptional Output of Mammary Epithelial Cells. J Mammary Gland Biol Neoplasia, 25(4): 351–366.
